Cargando…
Alternating dose-dense chemotherapy in patients with high volume disseminated non-seminomatous germ cell tumours
Only about half of patients with a poor-prognosis non-seminomatous germ-cell tumours can achieve a cure. The aim of this phase II study was to assess the efficacy and toxicity of a dose-dense alternating chemotherapy regimen in this subset of patients. High volume non-seminomatous germ-cell tumours...
Autores principales: | Fizazi, K, Prow, D M, Do, K-A, Wang, X, Finn, L, Kim, J, Daliani, D, Papandreou, C N, Tu, S-M, Millikan, R E, Pagliaro, L C, Logothetis, C J, Amato, R J |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2002
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2746595/ https://www.ncbi.nlm.nih.gov/pubmed/12085204 http://dx.doi.org/10.1038/sj.bjc.6600272 |
Ejemplares similares
-
The changing role of surgery in metastatic non-seminomatous germ cell tumour.
por: Cassidy, J., et al.
Publicado: (1992) -
Surgery in metastatic non-seminomatous germ cell tumours.
por: Tobias, J. S.
Publicado: (1992) -
Frequency of serum tumour marker monitoring in patients with non-seminomatous germ cell tumours.
por: Seckl, M. J., et al.
Publicado: (1990) -
The epidemiology of non-seminomatous germ cell tumours in the west of Scotland 1975-89.
por: Harding, M., et al.
Publicado: (1995) -
Glycan composition of serum alpha-fetoprotein in patients with hepatocellular carcinoma and non-seminomatous germ cell tumour
por: Johnson, P J, et al.
Publicado: (1999)